Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
For decades controversy has existed over the relative benefits of
colloid and crystalloid solutions for fluid resuscitation of
hypovolaemic patients. In their systematic review of randomised controlled trials Schierhout and Roberts (p 961) found that,
compared with crystalloids, use of colloids was associated with an
increase in absolute risk of mortality of 4%. There was no evidence
for differences of effect among different types of injury necessitating fluid resuscitation. The authors conclude that there is no evidence to
support the continued use of the more expensive colloids for acute
volume replacement in critically ill patients.